Roche and Kosan to Co-develop Anticancer Drug
By Business Review Editor
Pharma Deals Review: Vol 2002 Issue 29 (Table of Contents)
Published: 2 Oct-2002
DOI: 10.3833/pdr.v2002.i29.988 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Roche and Kosan Biosciences entered into an agreement to co-develop Kosan’s anti-tumor candidate, KOS-862 (Epothilone D)...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS